March 9 - 10, 2026 - Seoul
BioCentury and BayHelix will bring the 4th East-West Biopharma Summit back to Singapore in March 2025, working with local leaders. Singapore's government has invested in science, talent, and infrastructure for over 20 years, attracting top investors and opening new doors for partnerships and investment. As a gateway to Asia, Singapore connects industry leaders from an emerging Arc of Innovation, including Japan, Korea, China, Australia, India, and Southeast Asia. Join us for C-level networking, partnering and debate with peers from the East and West.
April 20 - 21, 2026 - Tokyo
Jointly organized between JAPhMed, PhRMA Japan and MAPS, the Japan Medical Affairs Summit has become the most influential annual gathering for Japan’s medical affairs professionals. New regulatory compliance directives continue to challenge the traditional commercial-driven business environment in Japan and a main goal of the Summit is to help break down the barriers between medical and commercial departments. The conference draws attendees from all levels- not only from the medical department, but also from other internal stakeholders including R&D, commercial and policy departments.
April 20 - 21, 2026 - Tokyo
China Healthcare Investment Conference (CHIC) is the premier gathering for investors, biotech and pharma executives, and dealmakers focused on China's life sciences sector. Each year, CHIC brings together leading venture capital and private equity firms, institutional investors, and the founders and executives building the next generation of Chinese healthcare companies for three days of high-level dialogue on financing, partnering, and cross-border investment. The first event of its kind when it launched in 2010, CHIC holds a unique place at the intersection of capital and innovation in the region.
September 16, 2026 - Seoul
AbbVie is seeking to explore exciting new cross-border licensing opportunities with innovative biotechs in Korea.
This event provides an opportunity to meet with senior research and partnership leadership teams to learn about AbbVie’s partnering strategies and interests.
If you feel your company may be a good fit for potential partnership consideration and would like to share information about your pipeline and discovery platforms, you may apply to meet with senior R&D and Corporate Strategy executives from AbbVie to discuss your ideas and research in an in-person one-on-one setting.
October 28 - 30, 2026 - Shanghai
Since its inception in 2008, the ChinaTrials Summit has been a cornerstone of the global clinical development industry — the forum where leaders gather to work through the field's most pressing trends and challenges.
As clinical development grows increasingly cross-border, the Summit brings global biopharma R&D perspectives together with a sharp focus on China and the wider Asia-Pacific region. At the center of the conversation: the speed of Chinese clinical development — the rapid enrollment and accelerated timelines that are reshaping how the industry thinks about getting assets to proof-of-concept. f you attend just one Summit on China clinical development this year, make it this one.
November 2 - 4, 2026 - Shanghai
For over a decade, the China Healthcare Summit has been the destination for biopharma leaders from Asia and the West to network, partner, and debate critical issues facing the industry.
At the 13th China Healthcare Summit, we will discuss how to reinvent your strategy. If you are a China biotech, it is time to reinvent your global strategy. If you are a global biopharma or investor, you must reinvent your China strategy.
Join BioCentury, BayHelix and Insights Partner McKinsey & Company in Shanghai for two days of networking, partnering and debate.
